» Articles » PMID: 20060366

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2010 Jan 12
PMID 20060366
Citations 405
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic lymphocytic leukemia (CLL) is a malignancy of B cells of unknown etiology. Deletions of the chromosomal region 13q14 are commonly associated with CLL, with monoclonal B cell lymphocytosis (MBL), which occasionally precedes CLL, and with aggressive lymphoma, suggesting that this region contains a tumor-suppressor gene. Here, we demonstrate that deletion in mice of the 13q14-minimal deleted region (MDR), which encodes the DLEU2/miR-15a/16-1 cluster, causes development of indolent B cell-autonomous, clonal lymphoproliferative disorders, recapitulating the spectrum of CLL-associated phenotypes observed in humans. miR-15a/16-1-deletion accelerates the proliferation of both human and mouse B cells by modulating the expression of genes controlling cell-cycle progression. These results define the role of 13q14 deletions in the pathogenesis of CLL.

Citing Articles

Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.

Hallek M Am J Hematol. 2025; 100(3):450-480.

PMID: 39871707 PMC: 11803567. DOI: 10.1002/ajh.27546.


Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.

Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S Epigenetics Chromatin. 2025; 18(1):3.

PMID: 39810224 PMC: 11734566. DOI: 10.1186/s13072-024-00560-8.


Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications.

Shabani M, Rostamzadeh D, Mansouri M, Jeddi-Tehrani M Avicenna J Med Biotechnol. 2024; 16(4):201-222.

PMID: 39606680 PMC: 11589431. DOI: 10.18502/ajmb.v16i4.16737.


The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia.

Zhang R, Khare P, Banerjee P, Ivan C, Schneider S, Barbaglio F Blood Cancer J. 2024; 14(1):168.

PMID: 39438453 PMC: 11496494. DOI: 10.1038/s41408-024-01142-3.


B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.

Weniger M, Seifert M, Kuppers R Methods Mol Biol. 2024; 2865:1-30.

PMID: 39424718 DOI: 10.1007/978-1-0716-4188-0_1.